EXTENSIONS OF THE MDR METHOD
EXTENSIONS OF THE MDR METHOD
批准号:
8171718
负责人:
Taeshin Park
金额:
$0.49万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-01 至 2011-07-31
关键词:
CategoriesCellsComplexComputer Retrieval of Information on Scientific Projects DatabaseConfidence IntervalsControl GroupsDataData AnalysesDiseaseEnvironmental Risk FactorFundingGenesGenotypeGrantInstitutionMeasuresMethodsModelingOdds RatioPerformancePredispositionResearchResearch PersonnelResourcesRiskRisk FactorsSourceUnited States National Institutes of Healthbasecase controldisorder riskgenetic associationhigh risksimulation
中文摘要
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
识别和表征增加常见复杂多因素疾病易感性的基因是遗传关联研究中的一项具有挑战性的任务。 里奇等人(2001)提出并实施了多因素降维(MDR)方法,以识别与特定疾病相关的多位点基因型和离散环境因素的组合。 然而,原始MDR方法基于病例和对照数量的比率的简单比较,以特设方式将多位点基因型的组合分类为高风险组和低风险组。当基因型组合中病例和对照的数量比例与整个数据中的比例相似时,或者当病例和对照的数量都很小时,这种方法容易出现假阳性和阴性错误。 我们开发了一种基于比值比的多因素降维(OR MDR)方法,该方法使用比值比作为疾病风险的新的定量度量,不仅提供了比值比作为风险的定量度量,而且还提供了从最高风险组到最低风险组的多位点组合的排序。 此外,该方法为每个多位点组合的比值比提供了置信区间,这在判断其作为危险因素的重要性方面是非常有用的。当考虑具有多维因子的高阶交互作用模型时,列联表中可能存在许多稀疏或空单元。 目前,MDR分析中有四种方法可用于处理缺失数据。第一种方法只使用没有缺失数据的完整观测,这可能导致严重的数据丢失。第二种方法是将缺失值视为额外的基因型类别,但结果的解释可能不清楚,结论可能会产生误导。此外,当病例组和对照组之间的缺失率不平衡时,它的表现很差。第三种方法是一种简单的插补方法,将缺失的基因型插补为最常见的基因型,这也可能产生偏倚结果。第四种方法,可用,使用给定位点的所有可用数据来增加功效。在任何真实的数据分析中,当存在缺失数据时,不清楚应该使用哪种MDR方法。我们考虑了一种新的EM Impute方法来更适当地处理缺失数据。通过仿真研究,我们比较了所提出的EM输入方法与当前方法的性能。我们的研究结果表明,可用和EM输入方法在功率和精度方面优于其他三种当前方法。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The identification and characterization of genes that increase the susceptibility to common complex multifactorial diseases is a challenging task in genetic association studies. The multifactor dimensionality reduction (MDR) method has been proposed and implemented by Ritchie et al. (2001) to identify the combinations of multilocus genotypes and discrete environmental factors that are associated with a particular disease. However, the original MDR method classifies the combination of multilocus genotypes into high-risk and low-risk groups in an ad hoc manner based on a simple comparison of the ratios of the number of case and controls. This method is prone to false positive and negative errors when the ratio of the number of cases and controls in a combination of genotypes is similar to that in the entire data, or when both the number of cases and controls is small. We developed an odds ratio based multifactor dimensionality reduction(OR MDR) method that uses the odds ratio as a new quantitative measure of disease risk, providing not only the odds ratio as a quantitative measure of risk, but also the ordering of the multilocus combinations from the highest risk to lowest risk groups. Furthermore, this method provides a confidence interval for the odds ratio for each multilocus combination, which is extremely informative in judging its importance as a risk factor. When a high-order interaction model is considered with multi-dimensional factors, there may be many sparse or empty cells in the contingency tables. Currently, there are four approaches available in MDR analysis to handle missing data. The first approach uses only complete observations that have no missing data, which can cause a severe loss of data. The second approach is to treat missing values as an additional genotype category, but interpretation of the results may then be not clear and the conclusions may be misleading. Furthermore, it performs poorly when the missing rates are unbalanced between the case and control groups. The third approach is a simple imputation method that imputes missing genotypes as the most frequent genotype, which may also produce biased results. The fourth approach, Available, uses all data available for the given loci to increase power. In any real data analysis, it is not clear which MDR approach one should use when there are missing data. We consider a new EM Impute approach to handle missing data more appropriately. Through simulation studies, we compared the performance of the proposed EM Impute approach with the current approaches. Our results showed that Available and EM Impute approaches perform better than the three other current approaches in terms of power and precision.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Numerical Tools for Predicting Drug Dissolution Profiles
-
批准号:9408999
-
项目类别:
-
资助金额:$45.09万
-
财政年份:2010
-
负责人:Taeshin Park
-
依托单位:
Numerical Tools for Predicting Drug Dissolution Profiles
-
批准号:7803031
-
项目类别:
-
资助金额:$12.02万
-
财政年份:2010
-
负责人:Taeshin Park
-
依托单位:
EXTENSIONS OF THE MDR METHOD
-
批准号:7956484
-
项目类别:
-
资助金额:$0.48万
-
财政年份:2009
-
负责人:Taeshin Park
-
依托单位:
EXTENSIONS OF THE MDR METHOD
-
批准号:7723447
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2008
-
负责人:Taeshin Park
-
依托单位:
EXTENSIONS OF THE MDR METHOD FOR DETECTING GENE-GENE INTERACTIONS
-
批准号:7600995
-
项目类别:
-
资助金额:$0.51万
-
财政年份:2007
-
负责人:Taeshin Park
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: